Menu Back toAgenda

DIA/FDA Oligonucleotide-Based Therapeutics Conference

DIA Your Way! Join us live in-person or live from the comfort of your home/office. This event offers two learning avenues depending on your preference!

Agenda

Day 1 Apr 25, 2022

7:00 AM — 4:45 PM Forum Registration
7:00 AM — 8:00 AM Networking Breakfast
8:00 AM — 9:00 AM Welcoming Remarks and Session 1: Keynote Address - The Coming of Age of Oligonucleotide-Based Therapeutics
9:00 AM — 10:30 AM Session 2: Plenary Session: When Innovation and Need Meet: Development of COVID-19 mRNA Vaccines
10:30 AM — 10:45 AM Refreshment and Networking Break
10:45 AM — 12:15 PM Session 3 Track 1: Clinical Development of Oligonucleotide Therapeutics for Viral and Kidney Diseases
10:45 AM — 12:15 PM Session 3 Track 2: Advances in Oligonucleotide Delivery
10:45 AM — 12:15 PM Session 3 Track 3: Platform Approaches and the Application of Prior Knowledge to the Development of Therapeutic Oligonucleotides
12:15 PM — 1:15 PM Networking Luncheon
1:15 PM — 2:45 PM Session 4 Track 1: Oligonucleotide Therapies for Brain and Eye Diseases: Learnings From Recent Clinical Trials
1:15 PM — 2:45 PM Session 4 Track 2: Off-Target Effects
1:15 PM — 2:45 PM Session 4 Track 3: CMC Perspective on Early and Late Stage Oligonucleotide Programs
2:45 PM — 3:15 PM Refreshment and Networking Break
3:15 PM — 4:45 PM Session 5 Track 1: Liver Targeted Therapeutics, Clinical Experience
3:15 PM — 4:45 PM Session 5 Track 2: Advances in CNS Delivery of Oligonucleotides
3:15 PM — 4:45 PM Session 5 Track 3: ICH Q14 Regulatory Perspective and the Impact on Process Analytical Technology
4:45 PM — 5:45 PM Poster Reception

Day 2 Apr 26, 2022

8:00 AM — 9:00 AM Networking Breakfast
8:00 AM — 4:30 PM Registration
9:00 AM — 10:00 AM Welcome to Day 2 and Session 6: Keynote Address - Delivery of Oligonucleotide Therapeutics – Going Beyond the Liver
10:00 AM — 10:30 AM Refreshment and Networking Break
10:30 AM — 12:00 PM Session 7 Track 1: Clinical Pharmacology Considerations in the Development and Approval of Oligonucleotide Therapeutics
10:30 AM — 12:00 PM Session 7 Track 2: RNA Activation
10:30 AM — 12:00 PM Session 7 Track 3: Oligonucleotide Delivery
12:00 PM — 1:15 PM Networking Luncheon with Round Table Discussions
1:15 PM — 2:45 PM Session 8 Track 1 and 2 – Individualized Antisense Oligonucleotide Drug Products
1:15 PM — 2:45 PM Session 8 Track 3: CMC Perspective on mRNA Therapeutics
2:45 PM — 3:15 PM Refreshment and Networking Break
3:15 PM — 4:45 PM Session 9: Hot Topics
4:45 PM — 5:45 PM DIA Oligonucleotide Safety Working Group (OSWG) – Open Meeting

Day 3 Apr 27, 2022

7:30 AM — 8:00 AM Networking Breakfast
7:30 AM — 12:00 PM Registration
8:00 AM — 9:30 AM Session 10 Track 1 and 2 – Alternative Approaches to Other Extrahepatic Delivery
8:00 AM — 9:30 AM Session 10 Track 3: CMC and Regulatory Experience for Novel Oligonucleotide Therapeutics
9:40 AM — 10:20 AM Session 11: PMDA Highlight - Recent Publication of Japanese Guideline for Non-clinical and CMC Topics Related to Oligonucleotide Medicines
10:20 AM — 10:45 AM Refreshment and Networking Break
10:45 AM — 12:00 PM Session 12: Co-track Grand Q&A Panel and Closing Remarks
12:00 PM — 12:00 PM Conference Adjourns

Contact us

Registration Questions?

Send Email
1.888.257.6457

Additional Information

Live Meeting Policies

Discover DIA’s Live In-Person and Live Virtual Events

DIA/FDA Oligonucleotide-Based Therapeutics Conference

Agenda

Day 1 Apr 25, 2022

Day 2 Apr 26, 2022

Day 3 Apr 27, 2022

Contact us

Registration Questions?

Additional Information

Be informed and stay engaged.